Visit COVID-19 resources

[Skip to Content]

Serial evaluation of retinal vascular changes in infants treated with intravitreal bevacizumab for aggressive posterior retinopathy of prematurity in zone I – (Eye Journal AOP)

20 November 2015

This news item is available to RCOphth members only, please log in below to access.

Members Login